arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Wednesday 4 July 2018

Wednesday 04 Jul

09:00

Plenary session: Interaction of Aspergillus fumigatus with neutrophilic granulocytes

Axel Brakhage, Germany

10:00

Break

10:30

Parallel session X

Parallel session X will take place from 10:30 hrs. until 12:00 hrs. and consists of six symposia.

S10.1 The technical revolutions ahead of us: NGS, proteomics, Crispr-cas

Convener: Sean Zhang, USA

10:30

S10.1a Genomic epidemiology of Candida auris within the United Kingdom, and the future of whole genome sequencing typing

Johanna Rhodes, United Kingdom

10:55

S10.1b Applications of mass spectrometry for rapid and accurate identification of molds and yeasts

Joanna Freeke, the Netherlands

11:20

S10.1c Disruption of cotH genes of Mucor circinelloides via a plasmid-free CRISPR/Cas9 system

Csilla Szebenyi, Hungry

11:45

S10.1d Using CRISPR/Cas9 to unravel the complex role of single nucleotide substitutions in Aspergillus fumigatus in-host adaptation

Eloise Ballard, United Kingdom

S10.2 ISHAM Working Group: Fungal PCR Initiative

Convener: Peter Donnelly, the Neterlands

10:30

S10.2a The FPCRI past, present and future

Rosemary Barnes, United Kingdom

10:55

S10.2b Laboratory aspects

Lewis White, United Kingdom

11:20

S10.2c Clinical and translational aspects

Mario Cruciani, Italy

11:45

Discussion

S10.3 ISHAM-EFISGsymposium: From non-responder to fungal breakthrough infections by opportunistic yeasts and molds

Conveners: Sevtap Arikan-Akdagli, Turkey & Cornelia Lass-Flörl, Austria

10:30

S10.3a How to define "non responder" and "fungal breakthrough" in yeasts and molds

Andreas Groll, Germany

10:55

S10.3b Current epidemiological trens: from prevalence to risk factors

Anastruey-Izquierdo, Spain

11:20

S10.3c How to manage treatment failures

Olivier Lortholary, France

11:45

S10.3d Breakthrough fungal infections in solid organ transplant (SOT) recipients receiving prophylaxis with isavuconazole and other antifungal agents

Cornelius Clancy, USA

S10.4 Ecology and outbreaks

Convener: Shawn Lockhart, USA

10:30

S10.4a Exploring the origin of outbreaks of mucormycosis

Karlyn Beer, USA

10:55

S10.4b Dimorphic fungi and species identification: Does it help us understand infection?

Marcus Teixeira, Brazil

11:20

S10.4c Candidiasis: What are we missing by only looking in the blood?

Hong Nguyen USA

11:45

S10.4d Epidemiological investigation for grouped cases of Trichosporon asahii using whole genome sequencing

M. Desnos-Ollivier, France

S10.5 Closing the mycetoma knowledge gap

Convener: Wendy van de Sande, the Netherlands & Ahmed Hassan Fahal, Sudan

10:30

S10.5a Assessing the global burden of mycetoma by the WHO

Kingsley Bampoe Asiedu, Switzerland

10:55

S10.5b Mycetoma treatment landscape

Ed Zijlstra, Switzerland

11:25

S10.5c Comparing different Isothermal amplification techniques in the diagnosis of eumycetoma

Sara Ahmed, Sudan

11:45

S10.5d Development of Madurella mycetomatis Short Tandem Repeat (MmySTR) assay for studying the genetic variance between different isolates

Bertrand Nyuykonge, the Netherlands

S10.6 Fungal respiratory infections in Cystic Fibrosis

Convener: Jean-Philippe Bouchara, France

10:30

S10.6a Treatment of airway colonization/respiratory infections with fungal pathogens

Carsten Schwarz, Germany

10:55

S10.6b Developing omics approaches to elucidate pathogenic mechanisms in Scedosporium species

Nicolas Papon, France

11:20

S10.6c Adaptation strategies of Aspergillus fumigatus in cystic fibrosis patients

Tobias Engel, the Netherlands

11:45

S10.6d Serum (1?3)-ß-D-glucan and galactomannan levels in patients with Cystic Fibrosis: a retrospective cohort study

Jürgen Held, Germany

S10.7 Candida auris

10:30

S10.7a Candida auris: report of the first case of infection from Australia

Christopher Heath, Australia

10:40

S10.7b Internal validation of GPS™ CanAur dtec-qPCR Test following the UNE/EN ISO/IEC 17025:2005 for detection of emergent nosocomial Candida auris

Antonio Martínez-Murcia, Spain

10:50

S10.7c Genetic diversity, phenotypic variability and drug resistance in the emerging fungal pathogen Candida auris

Alexandre Lorenz, United Kingdom

11:00

S10.7d Applicability of MALDI-TOF MS for rapid detection of resistant C. auris strains to caspofungin

Mansour Vatanshenassan, Germany

11:10

S10.7e Azole and echinocandin antifungal drug resistance determinants of Candida auris

Milena Kordalewska, USA

11:20

S10.7f Comparison of Candida auris candidemia with non-C. auris candidemia: risk factors and outcome experience from Pakistan

Joveria Farooqi, Pakistan

11:30

S10.7g Case-case comparison of Candida auris vs. other Candida species bloodstream infections in Colombia

Diego Cáceres, USA

11:40

S10.7h Candida auris in Germany – report of the first clinical cases of an emerging nosocomial pathogen

Axel Hamprecht, Germany

12:00

Closing ceremony